Your browser doesn't support javascript.
loading
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.
Tailor, Dhanir; Resendez, Angel; Garcia-Marques, Fernando Jose; Pandrala, Mallesh; Going, Catherine C; Bermudez, Abel; Kumar, Vineet; Rafat, Marjan; Nambiar, Dhanya K; Honkala, Alexander; Le, Quynh-Thu; Sledge, George W; Graves, Edward; Pitteri, Sharon J; Malhotra, Sanjay V.
Afiliación
  • Tailor D; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA 94304, USA; Department of Cell, Development and Cancer Biology, Kni
  • Resendez A; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Garcia-Marques FJ; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Pandrala M; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA 94304, USA; Department of Cell, Development and Cancer Biology, Kni
  • Going CC; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Bermudez A; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Kumar V; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Rafat M; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA.
  • Nambiar DK; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Honkala A; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Le QT; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Sledge GW; Department of Medicine, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Graves E; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Pitteri SJ; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
  • Malhotra SV; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA 94304, USA; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, CA 94304, USA; Department of Cell, Development and Cancer Biology, Kni
Cell Chem Biol ; 28(8): 1206-1220.e6, 2021 08 19.
Article en En | MEDLINE | ID: mdl-33713600

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_ovary_cancer Asunto principal: Neoplasias Ováricas / Proteína 1 de Unión a la Caja Y / Antineoplásicos Límite: Aged / Animals / Female / Humans / Middle aged Idioma: En Revista: Cell Chem Biol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_ovary_cancer Asunto principal: Neoplasias Ováricas / Proteína 1 de Unión a la Caja Y / Antineoplásicos Límite: Aged / Animals / Female / Humans / Middle aged Idioma: En Revista: Cell Chem Biol Año: 2021 Tipo del documento: Article
...